First Time Loading...
A

Aquestive Therapeutics Inc
NASDAQ:AQST

Watchlist Manager
Aquestive Therapeutics Inc
NASDAQ:AQST
Watchlist
Price: 4.07 USD 3.56% Market Closed
Updated: Apr 28, 2024

Aquestive Therapeutics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Aquestive Therapeutics Inc
Cash from Financing Activities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
A
Aquestive Therapeutics Inc
NASDAQ:AQST
Cash from Financing Activities
$4m
CAGR 3-Years
-48%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cash from Financing Activities
-$15.8B
CAGR 3-Years
-32%
CAGR 5-Years
3%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Cash from Financing Activities
-$9.4B
CAGR 3-Years
-101%
CAGR 5-Years
-22%
CAGR 10-Years
-24%
Pfizer Inc
NYSE:PFE
Cash from Financing Activities
$26.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Cash from Financing Activities
-$4.8B
CAGR 3-Years
-19%
CAGR 5-Years
18%
CAGR 10-Years
2%
Eli Lilly and Co
NYSE:LLY
Cash from Financing Activities
$3.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Aquestive Therapeutics Inc's Cash from Financing Activities?
Cash from Financing Activities
4m USD

Based on the financial report for Dec 31, 2023, Aquestive Therapeutics Inc's Cash from Financing Activities amounts to 4m USD.

What is Aquestive Therapeutics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-42%

Over the last year, the Cash from Financing Activities growth was -66%. The average annual Cash from Financing Activities growth rates for Aquestive Therapeutics Inc have been -48% over the past three years , -42% over the past five years .